Safety and efficacy of 3% diquafosol ophthalmic solution for soft contact lens-related dry eye.

Next Previous
Trial Profile

Safety and efficacy of 3% diquafosol ophthalmic solution for soft contact lens-related dry eye.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Mar 2018

At a glance

  • Drugs Diquafosol (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Santen Pharmaceutical

    • Most Recent Events

    • 19 Mar 2018 Status changed from active, no longer recruiting to completed.
    • 22 Nov 2017 Status changed from recruiting to active, no longer recruiting.
    • 27 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top